Figure 6F shows that STAD patients with a high score of Tcells CD8 had a favorable overall survival outcome, while STAD patients with a low score of T cells CD8 had a worse prognosis (p = 0.045 < 0.05). The gene discussed is CD8A; the disease is gastric adenocarcinoma.